U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
ONGERICIMAB
INN  
Official Name English
ongericimab [INN]
Common Name English
IMMUNOGLOBULIN G4, ANTI-(NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL JS002 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JS002 .KAPPA.-CHAIN, DIMER
Common Name English
JS 002
Code English
JS002
Common Name English
JS-002
Code English
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENSPCSK9 (PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC1, NARC-1, PROPROTEIN CONVERTASE 9, PC9)), HUMANIZED MONOCLONAL ANTIBODY
Common Name English
Code System Code Type Description
INN
11188
Created by admin on Sat Dec 16 15:39:44 GMT 2023 , Edited by admin on Sat Dec 16 15:39:44 GMT 2023
PRIMARY
FDA UNII
X126G5DZ36
Created by admin on Sat Dec 16 15:39:44 GMT 2023 , Edited by admin on Sat Dec 16 15:39:44 GMT 2023
PRIMARY
CAS
2145096-91-7
Created by admin on Sat Dec 16 15:39:44 GMT 2023 , Edited by admin on Sat Dec 16 15:39:44 GMT 2023
PRIMARY
NCI_THESAURUS
C174940
Created by admin on Sat Dec 16 15:39:44 GMT 2023 , Edited by admin on Sat Dec 16 15:39:44 GMT 2023
PRIMARY
ACTIVE MOIETY
ONGERICIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966